The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm
Lars Heslet1, Christiane Bay2, Steen Nepper-Christensen31Serendex ApS, Gentofte, Denmark; 2University of Copenhagen, Medical Faculty, Copenhagen, Denmark; 3Department of Head and Neck Surgery, Otorhinolaryngology, Køge Hospital, DenmarkBackground: Patients with cystic fibrosis (CF) ex...
Guardado en:
Autores principales: | Heslet L, Bay C, Nepper-Christensen S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b069854e66e24ccaaa9bfcfdb38cae8d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin DA, et al.
Publicado: (2013) -
Potential of anti-inflammatory treatment for cystic fibrosis lung disease
por: Jennifer L Taylor-Cousar, et al.
Publicado: (2010) -
Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis
por: Yan Fu, et al.
Publicado: (2021) -
High-Intensity Interval Training Improves Physical Function, Prevents Muscle Loss, and Modulates Macrophage-Mediated Inflammation in Skeletal Muscle of Cerebral Ischemic Mice
por: Lu Luo, et al.
Publicado: (2021) -
A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]
por: Kurukulaaratchy RJ, et al.
Publicado: (2021)